Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders | NLM

Disaster Information Management Research Center | NLM

Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders

01/01/2020 12:00 AM EST

Source: U.S. Government Accountability Office (GAO). Published: 1/2020. This 53-page report examines, among other things, how the Drug Enforcement Administration (DEA) obtains and uses industry-reported data to identify and address suspicious opioid orders, and opportunities for DEA to improve these efforts, such as using computer algorithms or real-time reporting. The study includes data and information on the prescription drug supply chain, identifies deficiencies associated with DEA’s drug diversion efforts, and makes four recommendations related to DEA’s collection and use of industry-reported data. (PDF)